(Q31462537)

2 July 2017

title

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription (English)

1 reference

glycogen metabolic process

2 July 2017

main subject

1 reference

Coghlan MP

1

1 reference

2 July 2017

Culbert AA

2

1 reference

2 July 2017

Cross DA

3

1 reference

2 July 2017

Corcoran SL

4

1 reference

2 July 2017

Yates JW

5

1 reference

2 July 2017

Pearce NJ

6

1 reference

2 July 2017

Rausch OL

7

1 reference

2 July 2017

Murphy GJ

8

1 reference

2 July 2017

Carter PS

9

1 reference

2 July 2017

Roxbee Cox L

10

1 reference

2 July 2017

Mills D

11

1 reference

2 July 2017

Brown MJ

12

1 reference

2 July 2017

Haigh D

13

1 reference

2 July 2017

Ward RW

14

1 reference

2 July 2017

Smith DG

15

1 reference

2 July 2017

Murray KJ

16

1 reference

2 July 2017

Reith AD

17

1 reference

2 July 2017

Holder JC

18

1 reference

2 July 2017

publication date

1 October 2000

1 reference

2 July 2017

published in

Chemistry and Biology

1 reference

2 July 2017

volume

7

1 reference

2 July 2017

issue

10

1 reference

2 July 2017

page(s)

793-803

1 reference

Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated prote

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Nerve and epidermal growth factor induce protein synthesis and eIF2B activation in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

A good antisense molecule is hard to find

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

A molecular mechanism for the effect of lithium on development

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Lithium therapy and signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

The development and therapeutic potential of protein kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Insulin stimulated glycogen synthesis in isolated rat hepatocytes: effect of protein kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Insulin-stimulated glycogen synthesis in cultured hepatoma cells: differential effects of inhibitors of insulin signaling molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

New insights into the role and mechanism of glycogen synthase activation by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900025-9

7 January 2021

10.1016/S1074-5521(00)00025-9

Identifiers

DOI

1 reference

2 July 2017

1 reference